查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401996

2030 年維生素 B6 原料藥市場預測：按類型、純度、應用和地區分類的全球分析

Vitamin B6 API Market Forecasts to 2030 - Global Analysis By Type (Capsules, Cream, Liquid and Injection, Syrup, Tablets and Other Types), Purity, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球維生素 B6原料藥市場規模為 2.216 億美元，預計到 2030 年將達到 4.051 億美元，預測期內複合年成長率為 9.0%。

在製藥業，維生素 B6原料藥藥物成分市場主要涉及生產、銷售和分銷藥用活性維生素 B6的部門。水溶性維生素 B6，也稱為吡哆醇，對於人體的新陳代謝、神經傳導物質合成和血紅蛋白的產生至關重要。解決各種健康問題和提高整體福祉是維生素 B6原料藥產業的重要目標。維生素 B6 是參與人體內多種代謝過程的重要輔酶，通常稱為吡哆醇。

Proactive health 的研究顯示，44% 的美國消費者在食品增加了營養補充的購買量。根據美國食品藥物管理局(FDA) 的數據，大約 28-36% 的普通人群使用含有維生素 B6（吡哆醇）的食品補充品。

健康意識不斷增強

隨著人們越來越認知到維生素 B6 在整體健康（包括代謝過程和神經健康）中發揮的重要作用，對維生素 B6 作為活性藥物成分的需求不斷增加。為了支持重要的生理活動並解決缺陷問題，消費者迫切尋求食品維生素 B6 的藥物配方和營養補充。此外，由於消費者越來越意識到維生素缺乏與許多健康問題和健康意識生活方式之間的聯繫，製藥和營養補充食品正在將維生素 B6原料藥涵蓋各種產品中。

發展中地區認知度低

在許多開發中國家，補充維生素 B6 的重要性及其健康益處尚未被廣泛了解。由於公眾和醫療專業人員對該問題缺乏了解，含有維生素 B6 活性成分的藥物原料藥的採用受到阻礙。由於缺乏對維生素 B6 在支持各種生物功能和解決營養缺乏方面的作用的了解，正在對相關產品市場產生負面影響。教育計劃和宣傳宣傳活動對於解決這一知識差距並為消費者和醫療保健專業人員提供他們所需的資訊以做出有關維生素 B6 補充劑的明智選擇至關重要。

高齡化率上升

世界高齡化正在加劇與老齡化相關的健康問題，例如心血管和神經系統疾病，其中一些疾病可能會受到維生素 B6 缺乏的影響。由於老年人通常難以充分吸收營養，因此補充維生素 B6 對於控制維生素 B6 缺乏和促進整體健康至關重要。維生素 B6原料藥是藥物配方中的關鍵成分，可滿足老年人獨特的健康需求，並有助於管理和預防與老齡化相關的疾病。

全球經濟挑戰

醫療保健支出和消費者購買力可能會受到景氣衰退和不確定時期的顯著影響。對藥品和營養補充劑（尤其是含有維生素 B6原料藥的藥品和營養補充）的需求下降可歸因於可支配收入的下降。在經濟狀況，補充品和衛生專業人員可能會優先考慮非必要的補充品，而不是基本健康需求所需的補充劑。製藥公司可能難以獲得研發計劃的資金籌措，這可能會阻礙創新產品的開發和推出。

COVID-19 的影響：

市場動態受到全球供應鏈中斷、旅行限制和消費者優先事項變化的影響。儘管由於健康意識的增強，營養補充食品基本上保持穩定，但製藥業在分銷和製造方面面臨挑戰。封鎖和物流困難可能會影響原料供應並導致工業流程延誤。此外，在整個大流行期間，消費者的購買模式受到經濟不確定性的影響，進而影響了非必需保健食品的購買。

膠囊細分市場預計將在預測期內成為最大的細分市場

膠囊提供了一種包裝維生素 B6原料藥的有效方法，確保給藥準確並易於涵蓋日常補充品方案中，因此膠囊細分市場在預測期內佔據了最大的市場佔有率。膠囊之所以受歡迎，是因為它們容易吞嚥，味道問題較少，而且維生素 B6 含量更穩定。此外，膠囊製劑帶來的便利性和精確給藥顯著增加了消費者的偏好，從而促進了這一領域的快速擴張。利用這一趨勢，製藥和營養補充食品推出了各種含有維生素B6原料藥的膠囊產品，以滿足注重健康的補充品市場。

預計肌肉痙攣部分在預測期內複合年成長率最高。

隨著維生素對肌肉相關問題的有效性得到證實，肌肉痙攣領域有望盈利的擴張。為了影響肌肉功能，維生素 B6 對於神經傳導物質的產生和胺基酸代謝至關重要。隨著人們越來越意識到肌肉痙攣和維生素 B6 缺乏之間的聯繫，他們正在積極尋找原料藥來預防和緩解這些不適。此外，正在開發有針對性的藥物和營養補充食品，以解決通常與這種重要物質的缺乏有關的肌肉疼痛。

佔有率最高的地區：

由於對預防性醫療保健的重視和健康意識的不斷提高，預計亞太地區將佔據最大的市場佔有率。隨著人們意識到補充維生素 B6 的重要性，含有維生素 B6原料藥的產品的消費率呈指數級成長。此外，消費者積極尋求改善整體健康和解決維生素缺乏的方法，推動了對維生素 B6 活性原料藥強化藥物製劑的需求。

複合年成長率最高的地區

預計亞太地區將出現盈利成長。政府促進健康和保健的措施以及越來越多擁有可支配資金的中等收入者創造了良好的市場環境。確保藥品品質和安全的法律規範增強了消費者信心，進一步支持該地區的市場擴張。此外，食品地區的營養補充和製藥部門也證明了其對新產品開發和技術創新的奉獻精神。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球維生素 B6原料藥市場：依類型

  • 介紹
  • 膠囊
  • 奶油
  • 液體和注射劑
  • 糖漿
  • 藥片
  • 其他類型

第6章全球維生素 B6原料藥市場：依純度

  • 介紹
  • 食品級
  • 飼料級

第7章全球維生素 B6原料藥市場：依應用分類

  • 介紹
  • 貧血
  • 不適
  • 失眠
  • 停經
  • 肌肉痙攣
  • 月經症候群
  • 保水能力
  • 製藥業
  • 食品和飲料業
  • 動物營養
  • 其他用途

第8章全球維生素 B6原料藥市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • DSM Sinochem Pharmaceuticals
  • Lonza Group Ltd
  • Hegno Pharmaceutical Co., Ltd
  • BASF SE
  • Dishman Carbogen Amcis Ltd
  • Zhejiang NHU Co., Ltd
  • Jiangxi Tianxin Pharmaceutical Co., Ltd
  • Huazhong Pharmaceutical Co., Ltd
  • Tianjin Zhongrui Pharmaceutical Co., Ltd
  • Anhui Sunhere Pharmaceutical Excipients Co., Ltd
  • Anhui Tiger Biotech Co., Ltd
  • Taizhou Tianrui Chemical Co., Ltd
  • Hubei Gedian Humanwell Pharmaceutical Co., Ltd
Product Code: SMRC24516

According to Stratistics MRC, the Global Vitamin B6 API Market is accounted for $221.6 million in 2023 and is expected to reach $405.1 million by 2030 growing at a CAGR of 9.0% during the forecast period. In the pharmaceutical industry, the market for Vitamin B6 API (Active Pharmaceutical Ingredient) pertains to the division that manufactures, sells, and distributes the active form of Vitamin B6, mostly for medicinal purposes. The water-soluble vitamin B6, also referred to as pyridoxine, is crucial for the body's metabolism, the synthesis of neurotransmitters, and the production of hemoglobin. Addressing a variety of health issues and enhancing general well-being are important objectives for the vitamin B6 API industry. A vital coenzyme involved in several metabolic processes in the human body is vitamin B6, often known as pyridoxine.

According to a survey by Proactive health, 44% of US consumers have increased purchases of dietary supplements during the pandemic. According to the U.S. Food and Drug Administration (FDA), about 28-36% of the normal population uses food supplements that contain vitamin B6 (pyridoxine).

Market Dynamics:

Driver:

Increasing health awareness

The demand for Vitamin B6 as an active pharmaceutical ingredient has increased as individuals become increasingly conscious of the critical role vitamins play in overall well-being, including metabolic processes and neurological health. In order to support vital physiological activities and handle inadequacies, consumers are diligently looking for pharmaceutical formulations and nutritional supplements enhanced with vitamin B6. Additionally, vitamin B6 API has been included in a variety of products by the pharmaceutical and nutraceutical industries as a result of growing consumer awareness of the connection between vitamin deficiencies and a number of health issues and health-conscious lifestyles.

Restraint:

Limited awareness in developing regions

The significance of vitamin B6 supplementation and its possible health benefits are not widely understood in many underdeveloped nations. The adoption of pharmaceutical formulations containing Vitamin B6 API is hampered by the general public's and healthcare professionals' lack of understanding of this issue. The market for related products is negatively impacted by a lack of knowledge on the role that vitamin B6 performs in supporting different biological functions and addressing nutritional deficits. To address this knowledge gap and provide consumers and healthcare professionals with the information they need to make informed choices about vitamin B6 supplementation, educational programs and awareness campaigns are crucial.

Opportunity:

Rising aging population

An aging population around the world has contributed to a rise in age-related health concerns, including cardiovascular disease and neurological diseases, several of which can be impacted by vitamin B6 deficiency. Supplementing with Vitamin B6 is essential for managing deficiencies and promoting general health because the senior population frequently experiences difficulties with adequate nutrient absorption. Vitamin B6 API is a crucial component of pharmaceutical formulations that address the unique health requirements of the elderly population and aid in the management and prevention of age-related illnesses.

Threat:

Global economic challenges

Spending on healthcare and consumer purchasing power can be severely impacted by economic downturns and periods of uncertainty. A decrease in the demand for medications and nutritional supplements, particularly those containing vitamin B6 API, may result from lower disposable income. In difficult financial times, individuals and healthcare professionals might give priority to non-essential supplements over those that are necessary for basic health needs. Pharmaceutical businesses might have problems obtaining funding for R&D projects, which could hinder their ability to innovate and launch innovative products.

COVID-19 Impact:

The market dynamics were impacted by disruptions in global supply chains, travel restrictions, and changes in consumer priorities. Due to growing health consciousness, the market for nutritional supplements remained mostly stable, but the pharmaceutical sector experienced difficulties with distribution and manufacture. Lockdowns and logistical difficulties impacted raw material supply, which could cause industrial processes to be delayed. Furthermore, throughout the pandemic, consumer buying patterns were impacted by economic uncertainty, which in turn affected the purchase of non-essential health products.

The capsules segment is expected to be the largest during the forecast period

Because capsules offer an effective means to package vitamin B6 API, ensuring precise dosing and simple incorporation into daily supplement regimens, the capsules sector held the largest share of the market over the projected period. The reason for the popularity of capsules is that they are easier to swallow, have fewer taste-related problems, and have better stability for the vitamin B6 that is inside. Moreover, due to the perceived convenience and accurate dosing that encapsulated formulations provide, consumer preferences have increased substantially, which has contributed to the segment's rapid expansion. Utilizing the benefit of this trend, pharmaceutical and nutraceutical businesses are launching a range of capsule products containing Vitamin B6 API to satisfy the market for wellness-focused supplements.

The muscular cramps segment is expected to have the highest CAGR during the forecast period

The muscle cramps area is anticipated to have profitable expansion due to the vitamin's established effectiveness in treating muscle-related problems. In order to affect muscular function, vitamin B6 is essential for the production of neurotransmitters and the metabolism of amino acids. As individuals become more aware of the connection between muscle cramps and vitamin B6 insufficiency, they are actively searching for formulations that contain vitamin B6 API in order to prevent and relieve these types of discomfort. Additionally, targeted pharmaceutical and nutraceutical solutions have been developed in response to muscle cramps, which are frequently associated with deficits in this vital substance.

Region with largest share:

Because of the increased emphasis on preventive healthcare and the development of health awareness, the Asia-Pacific region is expected to hold the largest proportion of the market. Vitamin B6 API-containing products are being consumed at an exponentially higher rate as people realize the significance of supplementing with nutrients. Additionally, demand for pharmaceutical formulations enhanced with Vitamin B6 API is being driven by consumers actively looking for ways to improve overall well-being and address vitamin deficiencies.

Region with highest CAGR:

Asia Pacific region is expected to hold profitable growth. A favorable market environment has been established by government measures that promote health and wellness as well as by the growing middle-class population with disposable funding. Consumer confidence has been bolstered by regulatory frameworks guaranteeing the quality and safety of pharmaceuticals, which has further propelled the market's expansion in the area. In addition, the Asia-Pacific region's nutraceutical and pharmaceutical sectors have proven their dedication to new product development and innovation.

Key players in the market:

Some of the key players in Vitamin B6 API market include DSM Sinochem Pharmaceuticals, Lonza Group Ltd, Hegno Pharmaceutical Co., Ltd, BASF SE, Dishman Carbogen Amcis Ltd, Zhejiang NHU Co., Ltd, Jiangxi Tianxin Pharmaceutical Co., Ltd, Huazhong Pharmaceutical Co., Ltd, Tianjin Zhongrui Pharmaceutical Co., Ltd, Anhui Sunhere Pharmaceutical Excipients Co., Ltd, Anhui Tiger Biotech Co., Ltd, Taizhou Tianrui Chemical Co., Ltd and Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

Key Developments:

In November 2023, BASF increases defoamer capacity at its Dilovasi plant in Turkey. New production line set up to meet growing demand for Foamaster® and Foamstar® products in South-East Europe, the Middle East and Africa. BASF will improve its service to customers in the region and reduce lead times to ensure faster delivery.

In November 2023, BASF receives funding approval for electrolysis plant. With the approval of funding from the German Federal Ministry for Economic Affairs and Climate Action and the State of Rhineland-Palatinate, BASF has taken a major step closer in building a PEM electrolyser for its project aimed at decarbonising the chemical industry.

Types Covered:

  • Capsules
  • Cream
  • Liquid and Injection
  • Syrup
  • Tablets
  • Other Types

Purities Covered:

  • Food Grade
  • Feed Grade

Applications Covered:

  • Anaemia
  • Fatigue
  • Insomnia
  • Menopausal Depression
  • Muscular Cramps
  • Premenstrual Syndrome
  • Water Retention
  • Pharmaceutical Industry
  • Food & Beverage Industry
  • Animal Nutrition
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vitamin B6 API Market, By Type

  • 5.1 Introduction
  • 5.2 Capsules
  • 5.3 Cream
  • 5.4 Liquid and Injection
  • 5.5 Syrup
  • 5.6 Tablets
  • 5.7 Other Types

6 Global Vitamin B6 API Market, By Purity

  • 6.1 Introduction
  • 6.2 Food Grade
  • 6.3 Feed Grade

7 Global Vitamin B6 API Market, By Application

  • 7.1 Introduction
  • 7.2 Anaemia
  • 7.3 Fatigue
  • 7.4 Insomnia
  • 7.5 Menopausal Depression
  • 7.6 Muscular Cramps
  • 7.7 Premenstrual Syndrome
  • 7.8 Water Retention
  • 7.9 Pharmaceutical Industry
  • 7.10 Food & Beverage Industry
  • 7.11 Animal Nutrition
  • 7.12 Other Applications

8 Global Vitamin B6 API Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 DSM Sinochem Pharmaceuticals
  • 10.2 Lonza Group Ltd
  • 10.3 Hegno Pharmaceutical Co., Ltd
  • 10.4 BASF SE
  • 10.5 Dishman Carbogen Amcis Ltd
  • 10.6 Zhejiang NHU Co., Ltd
  • 10.7 Jiangxi Tianxin Pharmaceutical Co., Ltd
  • 10.8 Huazhong Pharmaceutical Co., Ltd
  • 10.9 Tianjin Zhongrui Pharmaceutical Co., Ltd
  • 10.10 Anhui Sunhere Pharmaceutical Excipients Co., Ltd
  • 10.11 Anhui Tiger Biotech Co., Ltd
  • 10.12 Taizhou Tianrui Chemical Co., Ltd
  • 10.13 Hubei Gedian Humanwell Pharmaceutical Co., Ltd

List of Tables

  • Table 1 Global Vitamin B6 API Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 4 Global Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 5 Global Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 6 Global Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 7 Global Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 8 Global Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 9 Global Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 10 Global Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 11 Global Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 12 Global Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 14 Global Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 15 Global Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 16 Global Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 17 Global Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 18 Global Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 19 Global Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 20 Global Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 21 Global Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 22 Global Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 23 Global Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 North America Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 26 North America Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 27 North America Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 28 North America Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 29 North America Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 30 North America Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 31 North America Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 32 North America Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 33 North America Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 34 North America Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 35 North America Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 37 North America Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 38 North America Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 39 North America Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 40 North America Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 41 North America Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 42 North America Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 43 North America Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 44 North America Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 45 North America Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 46 North America Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 47 Europe Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 49 Europe Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 50 Europe Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 51 Europe Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 52 Europe Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 53 Europe Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 54 Europe Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 55 Europe Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 56 Europe Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 57 Europe Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 58 Europe Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 59 Europe Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 60 Europe Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 61 Europe Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 62 Europe Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 63 Europe Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 64 Europe Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 65 Europe Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 66 Europe Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 67 Europe Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 68 Europe Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 69 Europe Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 70 Asia Pacific Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 72 Asia Pacific Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 73 Asia Pacific Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 74 Asia Pacific Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 75 Asia Pacific Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 76 Asia Pacific Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 77 Asia Pacific Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 78 Asia Pacific Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 79 Asia Pacific Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 80 Asia Pacific Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 81 Asia Pacific Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 82 Asia Pacific Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 83 Asia Pacific Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 84 Asia Pacific Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 85 Asia Pacific Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 86 Asia Pacific Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 87 Asia Pacific Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 88 Asia Pacific Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 89 Asia Pacific Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 90 Asia Pacific Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 91 Asia Pacific Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 92 Asia Pacific Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 93 South America Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 95 South America Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 96 South America Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 97 South America Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 98 South America Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 99 South America Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 100 South America Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 101 South America Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 102 South America Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 103 South America Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 104 South America Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 105 South America Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 106 South America Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 107 South America Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 108 South America Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 109 South America Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 110 South America Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 111 South America Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 112 South America Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 113 South America Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 114 South America Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 115 South America Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 116 Middle East & Africa Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 118 Middle East & Africa Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 119 Middle East & Africa Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 120 Middle East & Africa Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 121 Middle East & Africa Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 122 Middle East & Africa Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 123 Middle East & Africa Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 124 Middle East & Africa Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 125 Middle East & Africa Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 126 Middle East & Africa Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 127 Middle East & Africa Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 128 Middle East & Africa Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 129 Middle East & Africa Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 130 Middle East & Africa Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 131 Middle East & Africa Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 132 Middle East & Africa Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 133 Middle East & Africa Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 134 Middle East & Africa Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 135 Middle East & Africa Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 136 Middle East & Africa Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 137 Middle East & Africa Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 138 Middle East & Africa Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)